GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 2.14M | — | $61.67M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.82M | — | $52.42M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 1.38M | — | $39.96M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 814.52K | — | $23.52M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 453.59K | — | $13.10M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 299.80K | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 84.75K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 66.18K | — | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 20.20K | — | $583,405 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 481 houders, 137.05M aandelen, $11.53B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 20.89K aand · $3.53M
Officer, Director · 7.59K aand · $1.29M
Officer, Director · 9.02K aand · $1.52M
Director · 116 aand · $18,148
Officer · 13.25K aand · $2.20M
Officer · 3.70K aand · $605,286
Officer · 9.93K aand · $1.63M
Officer · 19.01K aand · $3.14M
Officer · 400 aand · $67,168
Officer · 3.46K aand · $579,639
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie